Moleculin Biotech, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.6M | $-12.8M | $15.6M | $-25.4M | $-17.8M | $-5.9M | $-6.6M | $-7.0M |
| Depreciation & Amortization | $8.0K | $8.0K | $9.0K | $21.0K | $29.0K | $31.0K | $32.0K | $31.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $436.0K | $380.0K | $459.0K | $303.0K | $417.0K | $485.0K | $427.0K | $353.0K |
| Net Cash from Operating Activities | $-6.7M | $-6.1M | $-5.4M | $-7.2M | $-5.6M | $-4.6M | $-5.1M | $-6.1M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $0 | $0 | $0 | $0 | $0 | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $3.6M | $7.6M | $7.5M | $6.4M | $5.4M | $8.0M | $1.0K | $4.7M |
| Net Change in Cash | $-3.1M | $1.4M | $2.2M | $-854.0K | $-159.0K | $3.4M | $-5.1M | $-1.4M |
| Free Cash Flow | — | — | $-5.4M | $-7.2M | $-5.6M | $-4.6M | $-5.1M | $-6.1M |